UNSPSC 51173300: Combination rectal, local other

This classification denotes combination drugs and preparations which treat damaged, chafed areas. Typical combination other local rectal constituients are alcloxa and pramoxine.

UNSPSC 51173300 Combination rectal, local other is a Class code representing diagnostic and clinical specimen testing services—specifically drug screening, immunoassay testing, and pharmaceutical supply arrangements—that state and local health, corrections, and human services agencies procure. The code sees activity across corrections departments, state health agencies, and multi-state cooperative purchasing consortia. State and local buyers under this code source offender drug testing services including specimen collection, immunoassay screening with confirmation testing (LC/MS/MS, GC/MS, oral fluid, and hair testing), laboratory certification and result reporting, and generic pharmaceutical and OTC product supply through authorized wholesaler networks. Issuing bodies include county corrections and community supervision departments, state health and human services commissions, and multi-state cooperative purchasing organizations serving state and local government facilities.

Recent activity spans Texas and Minnesota. Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026 for offender specimen collection and drug testing services at two sites in Plano and McKinney, covering approximately 25,031 annual tests with an estimated contract value of $600,000 over two years with optional three-year renewals, with proposals due July 23, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in late March 2026 to gather market intelligence on direct-to-manufacturer prescription programs and pharmacy benefit management alternatives, reflecting exploratory procurement strategy. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities, with proposals due March 26, 2026 and contract effectiveness July 1, 2026, requiring vendors to supply through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC with pricing weighted at 75 percent of evaluation.